Publications by authors named "Samar Hamdy"

Claim this Profile
I
Immunoadjuvant activity of the nanoparticles' surface modified with mannan.
Azita Haddadi, Samar Hamdy, Zahra Ghotbi, John Samuel, Afsaneh Lavasanifar

Nanotechnology· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of antigen-specific T cell-responses by mannan-decorated PLGA nanoparticles.
Samar Hamdy, Azita Haddadi, Anooshirvan Shayeganpour, John Samuel, Afsaneh Lavasanifar

Pharm Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.
Samar Hamdy, Azita Haddadi, Ryan W Hung, Afsaneh Lavasanifar

Adv Drug Deliv Rev· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunosuppressive activity of polymeric micellar formulation of cyclosporine A: in vitro and in vivo studies.
Samar Hamdy, Azita Haddadi, Anooshirvan Shayeganpour, Aws Alshamsan, Hamidreza Montazeri Aliabadi

AAPS J· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo.
Aws Alshamsan, Samar Hamdy, Azita Haddadi, John Samuel, Ayman O S El-Kadi

Transl Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active targeting of dendritic cells with mannan-decorated PLGA nanoparticles.
Zahra Ghotbi, Azita Haddadi, Samar Hamdy, Ryan W Hung, John Samuel

J Drug Target· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part II: targeted particles for imaging of anticancer immune responses.
Ryan W Hung, Samar Hamdy, Azita Haddadi, Zahra Ghotbi, Afsaneh Lavasanifar

Curr Drug Deliv· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part I: targeted particles for cancer immunotherapy.
Samar Hamdy, Azita Haddadi, Zahra Ghotbi, Ryan W Hung, Afsaneh Lavasanifar

Curr Drug Deliv· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response.
Aws Alshamsan, Azita Haddadi, Samar Hamdy, John Samuel, Ayman O S El-Kadi

Mol Pharm· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a poly(d,l-lactic-co-glycolic acid) nanoparticle formulation of STAT3 inhibitor JSI-124: implication for cancer immunotherapy.
Ommoleila Molavi, Abdullah Mahmud, Samar Hamdy, Ryan W Hung, Raymond Lai

Mol Pharm· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine.
Aws Alshamsan, Samar Hamdy, John Samuel, Ayman O S El-Kadi, Afsaneh Lavasanifar

Biomaterials· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of bone marrow derived dendritic cells as an appropriate model to study tumor-mediated suppression of DC maturation through STAT3 hyperactivation.
Aws Alshamsan, Samar Hamdy, Saswati Das, Afsaneh Lavasanifar, John Samuel

J Pharm Pharm Sci· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunomodulatory and anticancer effects of intra-tumoral co-delivery of synthetic lipid A adjuvant and STAT3 inhibitor, JSI-124.
Ommoleila Molavi, Zengshuan Ma, Samar Hamdy, Afsaneh Lavasanifar, John Samuel

Immunopharmacol Immunotoxicol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model.
Ommoleila Molavi, Zengshuan Ma, Samar Hamdy, Raymond Lai, Afsaneh Lavasanifar

Immunol Cell Biol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity.
Samar Hamdy, Ommoleila Molavi, Zengshuan Ma, Azita Haddadi, Aws Alshamsan

Vaccine· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical analysis of synthetic lipid A-based vaccine adjuvants in poly (D,L-lactic-co-glycolic acid) nanoparticle formulations.
Samar Hamdy, Azita Haddadi, Vishwa Somayaji, David Ruan, John Samuel

J Pharm Biomed Anal· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
Samar Hamdy, Praveen Elamanchili, Aws Alshamsan, Ommoleila Molavi, Tadaaki Satou

J Biomed Mater Res A· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
Praveen Elamanchili, Christine M E Lutsiak, Samar Hamdy, Manish Diwan, John Samuel

J Immunother· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a sensitive and specific liquid chromatography/mass spectrometry method for the quantification of cucurbitacin I (JSI-124) in rat plasma.
Ommoleila Molavi, Anooshirvan Shayeganpour, Vishwa Somayaji, Samar Hamdy, Dion R Brocks

J Pharm Pharm Sci· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotyping of the N-acetyltransferase2 polymorphism in the prediction of adverse drug reactions to isoniazid in Japanese patients.
Masahiro Hiratsuka, Yukinaga Kishikawa, Yoh Takekuma, Masaki Matsuura, Kaori Narahara, Samar Ismail Hamdy

Drug Metab Pharmacokinet· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population.
Samar I Hamdy, Masahiro Hiratsuka, Kaori Narahara, Naomi Endo, Mervat El-Enany

Br J Clin Pharmacol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian population.
Samar I Hamdy, Masahiro Hiratsuka, Kaori Narahara, Naomi Endo, Mervat El-Enany

Br J Clin Pharmacol· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allele and genotype frequencies of CYP2B6 and CYP3A5 in the Japanese population.
Masahiro Hiratsuka, Yoh Takekuma, Naomi Endo, Kaori Narahara, Samar Ismail Hamdy

Eur J Clin Pharmacol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.
Samar Ismail Hamdy, Masahiro Hiratsuka, Kaori Narahara, Mervat El-Enany, Nadia Moursi

Br J Clin Pharmacol· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allele and genotype frequencies of polymorphic DCP1, CETP, ADRB2, and HTR2A in the Egyptian population.
Samar Ismail Hamdy, Masahiro Hiratsuka, Kaori Narahara, Mervat El-Enany, Nadia Moursi

Eur J Clin Pharmacol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis